#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14814	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2497	729.9	0	.	n	.	0	C1450T	SNP	1450	1450	C	1880	1880	T	1014	T,C	1010,3	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14814	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2497	729.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1614	1614	C	886	C,A	885,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24816	23S	2890	2890	99.83	23S.l15.c4.ctg.1	4059	761.9	0	.	n	.	0	T695C	SNP	695	695	T	1280	1280	C	940	C,T,A	938,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24816	23S	2890	2890	99.83	23S.l15.c4.ctg.1	4059	761.9	0	.	n	.	0	A1638G	SNP	1638	1638	A	2223	2223	G	943	G	943	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24816	23S	2890	2890	99.83	23S.l15.c4.ctg.1	4059	761.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2556	2556	C	792	C	792	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24816	23S	2890	2890	99.83	23S.l15.c4.ctg.1	4059	761.9	0	.	n	.	0	C2194T	SNP	2194	2194	C	2779	2779	T	780	T,C,A	778,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24816	23S	2890	2890	99.83	23S.l15.c4.ctg.1	4059	761.9	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3182	3182	T	856	T,C,A,G	851,3,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24816	23S	2890	2890	99.83	23S.l15.c4.ctg.1	4059	761.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2630	2630	A	721	A	721	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	27	2084	folP	852	852	100.0	folP.l6.c17.ctg.1	2114	123.0	1	SNP	p	R228S	0	.	.	682	684	CGC	1361	1363	CGC	196;198;199	C,A;G;C,G	195,1;198;198,1	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4576	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3879	147.2	1	SNP	p	S91F	0	.	.	271	273	TCC	887	889	TCC	174;172;173	T;C;C	174;172;173	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4576	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3879	147.2	1	SNP	p	D95G	0	.	.	283	285	GAC	899	901	GAC	171;169;168	G,A;A;C	170,1;169;168	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4576	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3879	147.2	1	SNP	p	D95N	0	.	.	283	285	GAC	899	901	GAC	171;169;168	G,A;A;C	170,1;169;168	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	1888	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1772	133.0	1	SNP	p	G45D	1	.	.	133	135	GAC	687	689	GAC	203;205;207	G;A,T,C;C	203;203,1,1;207	mtrR.WHO_M_01390:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1136	mtrR_promoter	250	250	99.2	mtrR_promoter.l15.c4.ctg.1	1390	101.7	0	.	n	.	0	T10C	SNP	10	10	T	584	584	C	203	C	203	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1136	mtrR_promoter	250	250	99.2	mtrR_promoter.l15.c4.ctg.1	1390	101.7	0	.	n	.	0	A197.	DEL	197	197	A	770	770	A	210	A	210	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4712	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3511	167.4	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1744	1746	ATC	217;218;219	A,G;T;C,T	216,1;218;218,1	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4712	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3511	167.4	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1897	1899	GCA	235;236;236	G,A;C;A	234,1;236;236	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4712	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3511	167.4	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2380	2382	ATT	228;229;226	A;T;T	228;229;226	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4712	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3511	167.4	1	SNP	p	D86N	0	.	.	256	258	GAC	850	852	GAC	175;175;177	G;A;C	175;175;177	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4712	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3511	167.4	1	SNP	p	S87W	0	.	.	259	261	AGT	853	855	AGT	177;178;181	A,G;G,T;T	176,1;177,1;181	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4712	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3511	167.4	1	SNP	p	S87I	0	.	.	259	261	AGT	853	855	AGT	177;178;181	A,G;G,T;T	176,1;177,1;181	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4712	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3511	167.4	1	SNP	p	S87R	0	.	.	259	261	AGT	853	855	AGT	177;178;181	A,G;G,T;T	176,1;177,1;181	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4712	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3511	167.4	1	SNP	p	S88P	0	.	.	262	264	TCC	856	858	TCC	182;184;190	T;C;C,G	182;184;189,1	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	3984	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3119	159.3	0	.	p	.	0	G168S	NONSYN	502	504	GGC	1053	1055	AGC	202;203;204	A;G,C;C	202;202,1;204	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	3984	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3119	159.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1779	1781	GGC	245;247;245	G,C;G,T;C,A	244,1;246,1;244,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	4410	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2848	193.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1492	1494	GCA	239;239;240	G;C;A	239;239;240	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4410	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2848	193.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1495	1497	ATC	241;241;244	A;T;C	241;241;244	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4410	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2848	193.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1507	1509	GTG	243;247;246	G;T,A;G	243;246,1;246	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4410	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2848	193.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1507	1509	GTG	243;247;246	G;T,A;G	243;246,1;246	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4410	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2848	193.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2011	2013	ACC	261;260;258	A;C;C	261;260;258	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4410	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2848	193.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2065	2067	GCG	246;246;245	G;C,T;G,A	246;245,1;244,1	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4410	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2848	193.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2065	2067	GCG	246;246;245	G;C,T;G,A	246;245,1;244,1	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4410	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2848	193.1	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2188	2190	GGT	261;261;264	G,T;G;T	260,1;261;264	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4410	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2848	193.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2197	2199	GGC	256;260;258	G;G,T;C	256;258,2;258	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4410	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2848	193.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2215	2217	CCG	264;263;264	C,A;C;G,T	263,1;263;263,1	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5430	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3505	193.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1802	1804	CCG	223;223;221	C;C;G,T	223;223;220,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2010	porA	1146	1146	99.65	porA.l6.c4.ctg.1	2390	104.9	0	.	p	.	0	S22G	NONSYN	64	66	AGC	728	730	GGC	140;142;144	G,C;G;C	139,1;142;144	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2010	porA	1146	1146	99.65	porA.l6.c4.ctg.1	2390	104.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	910	910	C	158	C	158	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3008	porB1b	1047	1047	99.71	porB1b.l6.c17.ctg.1	2026	184.6	0	.	p	.	0	G120D	NONSYN	358	360	GGC	859	861	GAC	249;251;251	G;A;C,A	249;251;250,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3008	porB1b	1047	1047	99.71	porB1b.l6.c17.ctg.1	2026	184.6	1	SNP	p	D121N	1	D121N	NONSYN	361	363	GAC	862	864	AAC	253;254;256	A;A;C,T	253;254;255,1	porB1b.WHO_P_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3008	porB1b	1047	1047	99.71	porB1b.l6.c17.ctg.1	2026	184.6	0	.	p	.	0	E212K	NONSYN	634	636	GAA	1135	1137	AAA	278;280;278	A;A,C;A,T	278;279,1;277,1	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	10174	rpoB	4179	4179	100.0	rpoB.l15.c30.ctg.1	5298	239.4	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2160	2162	CAT	273;273;273	C;A;T	273;273;273	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1404	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1370	127.3	1	SNP	p	V57M	1	.	.	169	171	ATG	681	683	ATG	237;238;238	A;T,C;G	237;237,1;238	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
